Ledger.Open graph →
SEC Form D · filed November 10, 2022

TriSalus Life Sciences, Inc

Offering
$23.5M
Sold
$23.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WESTMINSTER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Gene Mcgrevin · WESTMINSTER, CODirectorRaj L. Mistry · Westminster, COExecSimone Song · Westminster, CODirectorMary T. Szela · Westminster, COExec · DirectorAnil Singhal · WESTMINSTER, CODirectorMats L. Wahlstrom · WESTMINSTER, CODirectorJohn L. Tullis · Westminster, CODirectorSean Murphy · Westminster, COExec · DirectorDiane Parks · Westminster, CODirectorKerry Hicks · Westminster, CODirectorChristopher T. Ladd · Bentonville, ARDirectorElisabeth Cullington · Bend, ORExec · DirectorS. James Miller Jr · Bend, ORDirectorStefan T. Sterns · Bentonville, ARDirectorDean D. Varner · TAMPA, FLDirectorKelly Ortiz · OAKBROOK TERRACE, ILExecShaun Madden · Bend, ORDirectorMark A. Buis · Southfield, MIDirectorKyle J. Charters · Durham, NCDirectorEva Maglis · Toronto, Ontario, CanadaExec · DirectorMark Mccurdy, M.D · Fort Worth, TXExec · DirectorAjith Pai · Fort Worth, TXDirectorJulie Elsey · Fort Worth, TXDirectorWilliam Crawford · Fort Worth, TXDirectorRebecca Tucker · Fort Worth, TXDirectorBrett Truka · Chula Vista, CAExec · DirectorNehemiah R. Stewart · Chapel Hill, NCDirectorZachary D. Schrank · Chapel Hill, NCDirectorSignalfire Xir Venture Fund Ii GP, L.L.C · SAN FRANCISCO, CADirectorSze Chyi G. Lim · Singapore, U0Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗